《公司业绩》维他奶(00345.HK)半年纯利6.72亿元升26% 中期息维持3.8仙
维他奶国际(00345.HK)公布截至今年9月底止中期业绩,营业额44.1亿元,按年跌5.9%。纯利6.72亿元,按年升26%;每股盈利63.1仙。派中期息3.8仙,按年持平。
期内,毛利为24.1亿元,按年下跌6%,主要由於销量减少。经营溢利按年上升28.7%至9.29亿元,主因适时谨慎成本控制,根据疫情发展而更改分阶段投资的计划,以及疫情期间某些市场当地政府给予的补贴。撇除政府补贴,经营溢利增长10%。EBITDA则增加27%至11.52亿元,主要由於经营费用减少加上获得政府补贴所致。
另外,期内毛利率维持55%,主要由於政府补贴,但部分被原材料(尤其是糖及奶粉)的不利价格所抵销。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.